propentofylline has been researched along with Chronic Illness in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of propentofylline on the expressions of glial fibrillary acidic protein (GFAP) and TNF-alpha and its action mechanism in the rat model of chronic prostatitis pain (CPP)." | 7.78 | [Inhibitory effect of propentofylline on chronic prostatitis pain in rats and its mechanism]. ( Guo, YT; Liu, C; Zhang, J, 2012) |
| "Propentofylline is a novel xantine derivative which is being developed for treatment of degenerative and vascular dementia." | 6.73 | A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. ( Abbasi, SH; Ahmadi-Abhari, SA; Akhondzadeh, S; Derakhshan, MK; Fotouhi, A; Ghoreishi, A; Hajiazim, M; Khodaie-Ardakani, MR; Mohammadi, MR; Noorbala, AA; Salimi, S, 2008) |
| "Propentofylline is a unique methylxanthine with clear cyclic AMP, phosphodiesterase, and adenosine actions, including enhanced synaptic adenosine signaling." | 6.47 | Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. ( De Leo, J; Sweitzer, S, 2011) |
| "To investigate the effects of propentofylline on the expressions of glial fibrillary acidic protein (GFAP) and TNF-alpha and its action mechanism in the rat model of chronic prostatitis pain (CPP)." | 3.78 | [Inhibitory effect of propentofylline on chronic prostatitis pain in rats and its mechanism]. ( Guo, YT; Liu, C; Zhang, J, 2012) |
| "Propentofylline is a novel xantine derivative which is being developed for treatment of degenerative and vascular dementia." | 2.73 | A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia. ( Abbasi, SH; Ahmadi-Abhari, SA; Akhondzadeh, S; Derakhshan, MK; Fotouhi, A; Ghoreishi, A; Hajiazim, M; Khodaie-Ardakani, MR; Mohammadi, MR; Noorbala, AA; Salimi, S, 2008) |
| "Propentofylline is a unique methylxanthine with clear cyclic AMP, phosphodiesterase, and adenosine actions, including enhanced synaptic adenosine signaling." | 2.47 | Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. ( De Leo, J; Sweitzer, S, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sweitzer, S | 1 |
| De Leo, J | 1 |
| Zhang, J | 1 |
| Liu, C | 1 |
| Guo, YT | 1 |
| Salimi, S | 1 |
| Fotouhi, A | 1 |
| Ghoreishi, A | 1 |
| Derakhshan, MK | 1 |
| Khodaie-Ardakani, MR | 1 |
| Mohammadi, MR | 1 |
| Noorbala, AA | 1 |
| Ahmadi-Abhari, SA | 1 |
| Hajiazim, M | 1 |
| Abbasi, SH | 1 |
| Akhondzadeh, S | 1 |
1 review available for propentofylline and Chronic Illness
| Article | Year |
|---|---|
Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain.
Topics: Animals; Chronic Disease; Drug Tolerance; Humans; Morphine; Neuroglia; Neuroprotective Agents; Pain; | 2011 |
1 trial available for propentofylline and Chronic Illness
| Article | Year |
|---|---|
A placebo controlled study of the propentofylline added to risperidone in chronic schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female | 2008 |
1 other study available for propentofylline and Chronic Illness
| Article | Year |
|---|---|
[Inhibitory effect of propentofylline on chronic prostatitis pain in rats and its mechanism].
Topics: Animals; Astrocytes; Chronic Disease; Chronic Pain; Glial Fibrillary Acidic Protein; Male; Prostatit | 2012 |